By (844) 549-0883 Xarelto Lawsuit Updates and News

Xarelto Lawsuit Claims

Xarelto Lawsuit Claims

Xarelto Lawsuit Claims: How Long Will A Xarelto Lawsuit Take?

One of the many questions we get from our clients on Xarelto Lawsuit Claims and
during intake is a) whether there have been any Xarelto settlements to
date and b) how long will a Xarelto settlement take. The first lawsuits
filed alleging that Xarelto caused internal bleeding, which resulted in
serious injury or death, were filed against the manufacturers of the
blood thinner in early 2014. These bleeding events include:

We really are in the infancy of this litigation. It will take several
years for the litigation to progress through the judicial system whereby
we believe Bayer AG and Johnson & Johnson will likely have to pay out
substantial compensation to those injured or families who have lost a
loved one due to the side effects of Xarelto.

Xarelto Lawsuit Claims - Xarelto Settlement And Litigation Process

Filing Of Lawsuits

The first phase will be the filing of Xarelto complaints in various
jurisdictions around the country, in both state and federal court. These
complaints will layout the basis of the Xarelto lawsuit and will
identify the damage, pain and suffering endured by the plaintiff.

Based on the numbers of prescriptions of Xarelto issued, and the
incidence of an adverse event from the scientific studies, we believe
there will be thousands of lawsuits filed alleging that Xarelto caused
an adverse event such as an uncontrollable internal bleed which lead to
severe injuries or death.

Formation Of MDL

At the end of 2014, the Xarelto litigation advanced to the next phase
where all federal filed Xarelto lawsuits were centralized under an MDL
or Multidistrict Litigation group at the Eastern District of Louisiana
under presiding District Judge Eldon Fallon. Once a mass tort has
several filings, either party can petition the court to consolidate the
claims in an MDL which will expedite the cases and conserve judicial
resources. This mechanism enables lawyers to focus on organization of
cases, and discovery in preparation for initial trials and settlement
talks. This process will take at least one year.

The First Xarelto Trials

Upon completion of discovery, designated plaintiffs counsel will
identify several cases from the pool of cases that are ready for trial.
These cases are known as “bellweather cases”. These trials are not
expected to take place before 2016. Each trial will take at least one
month, and the verdict of each trial will be an indication of the
settlement value of a Xarelto lawsuit.

Xarelto Settlement

Settlement negotiations will likely take place in 2016 at the earliest
where the defendants will likely settle all the federal cases in one
mass settlement. This is similar to how the Pradaxa blood thinner
litigation played out where they settled 4,000 cases for $650 million.
If no settlement is reached, trials will continue to be scheduled.

Determining Factors At Xarelto Settlements

From meeting our clients and speaking with several victims, we
understand the hardship and pain endured by the people who suffered an
adverse event. The settlement negotiations will specifically focus on
the factors that a jury would take into account what a jury will take
into account at trial. These key factors include:

what injury was suffered as a result of taking Xarelto?

how long did the injury last?

what were the short term and long term effects of the injury on the
plaintiff?

what future care might be needed?

in the event of death, what financial compensation will no longer be
available to dependents?

in the event of disability, what economic loss will be suffered in the
future because of an inability to work?

in a wrongful death xarelto case, to what extent will loss of
companionship exist because of the loss of a loved one?

what medical expenses were incurred in the past?

what medical expense will be incurred in the future?

what burial or funeral expenses were incurred?

Xarelto News & Updates Timeline - Xarelto Lawsuit Claims

The anticoagulant drug Xarelto represents a new class of blood thinning
medications meant to replace Coumadin and warfarin. With claims of fewer
side effects and easier prescribing restrictions for patients, the joint
effort from Bayer and Johnson & Johnson has already surpassed
competitors Eliquis and Pradaxa with over $1 billion in sales.

Nonetheless, the advent of these
next-generation blood thinners hasn’t been all
good. Professionals have
weighed in with warnings that they may
trigger much
more significant internal bleeding
dangers than warfarin because there isn’t yet an antidote for extreme
hemorrhaging.

Customer watchdog groups tracking adverse event
reports for the FDA have noted a huge number of patient complications, and a
number of hundred deaths filed using the agency.

And now, with the number of lawsuits alleging internal bleeding
hospitalization from Xarelto on the rise around the country, lawyers
have asked that cases be moved to a special drug injury federal court (read
more).

Xarelto Lawsuit Status Update: January 31, 2017

Reviewing Expert Testimony

The federal court Xarelto cases continue to move forward. Numerous
expert reports have been exchanged by the parties and depositions of the
experts have been taken.

At this point, Xarelto is in the legal briefing period, where both
parties test the legal validity of each other’s expert reports. A
hearing has been set in March of 2017 by the Honorable Eldon J. Fallon
to hear argument about the legal validity of the Xarelto experts’
reports and depositions.

After that hearing, Judge Fallon will issue an opinion about the
experts. The opinion will frame the Xarelto litigation for the parties.
After the opinion is issued, if the experts are found to be sound, the
cases are expected to proceed to trial.

In the Philadelphia County Xarelto litigation, the parties have picked
24 cases for trial work up and the depositions are ongoing. After the
depositions are finished, a smaller pool of cases will be picked to be
worked up further for trial.

Here, we are working vigorously to proceed in both Federal Court and in
Philadelphia County to pursue our client’s claims.

Xarelto Lawsuit Status Update: January 3, 2017

There are now almost 14,000 cases pending in the Xarelto MDL. US
District Judge Eldon Fallon of the Eastern District of Louisiana will
hear the first case in March 2017 from plaintiff Joseph Boudreaux. Mr.
Boudreaux was hospitalized in early 2014 shortly after he started using
Xarelto to help control his atrial fibrillation. He required multiple
blood transfusions and has accused Janssen and Bayer of misrepresenting
the safety profile of Xarelto.

Other Xarelto bellwether trials are scheduled for April 24 and May 30.
More Xarelto lawsuits are being filed in courts around the country –
learn more about Xarelto lawsuits here.

Xarelto Lawsuit Status Update: September 27, 2016

Deposition of Defendants’ Witnesses Almost Complete – Defendants Say
They Will Not Settle Cases

The Xarelto case continues to move at a fast pace. The depositions of
Defendants’ witnesses are almost completed and expert reports are due by
mid November 2016. The parties will then take depositions of the experts.

The Defendants repeatedly say that the case will not settle, so the
parties are expecting to try a lot of cases. In Federal Court, the first
four trials have been delayed a little but there should be four cases
tried to verdict by early Summer, 2017.

In Philadelphia, 10 trials are set for trial beginning at the end of
Summer 2017, with cases being tried every two weeks for basically the
rest of 2017.

Depositions of plaintiffs, medical providers and sales representatives
continues in federal court and those depositions should be completed by
October 3, 2016.

A very important date in the litigation is February 10, 2017, when the
court will hear arguments about whether each parties experts should be
allowed to testify. Basically, an expert is allowed to testify if the
expert’s opinion is based on generally accepted science and the expert’s
testimony will be helpful to the jury.

There are approximately 5,000 Xarelto cases filed in state and federal
court. There are more cases filed every week. Fortunately, there are two
very experienced judges managing the ligation. Lawyers from Nastlaw have
devoted countless hours to working in the federal and state litigation.
At Nastlaw, we firmly believe in working in both courts so our clients
receive the best representation possible.

Xarelto Lawsuit Status Update: August 17, 2016

17 Xarelto Trials Scheduled for 2017

The Xarelto litigation is on track for 17 trials on 2017. This is an
unusually fast pace for a large mass tort. In Xarelto, 17 cases will be
tried in under three years from the date the first Xarelto lawsuit was
filed.

The fast pace of Xarelto is due to a unique combination of factors:

First, the vast majority of the cases on Xarelto Lawsuit Claims are being managed by
two experienced and effective judges. In Federal Court, the Honorable
Eldon Fallon is managing the litigation. In the past, Judge Fallon has
managed several large MDLs, including Vioxx. In State Court, the
Honorable Arnold New is managing the litigation. Judge New has managed
numerous mass torts, including Yaz.

Second, Judge New and Judge Fallon have appointed lawyers to manage the
litigation that have devoted their careers to mass torts. At NastLaw,
Judge Fallon has appointed Dianne Nast to the Plaintiffs Steering
Committee. Judge Fallon has also appointed Daniel Gallucci as a state
liaison to the Federal Litigation. Judge New has appointed Daniel
Gallucci as a co-liaison, which is the functional equivalent of co-lead
counsel in the Xarelto Litigation.

This combination of experienced judges and experienced lawyers,
hopefully, will result in injured plaintiffs getting their day in court
with a speed that is virtually unheard of in mass tort litigation.

First Four Xarelto Trials Identified

On August 17, 2016, the the Honorable Eldon Fallon, who manages the
Federal Xarelto litigation entered a case management order identifying
the four cases that will be tried in federal court.

Judge Fallon identified the following cases for trial:

Trial 1: The matter of Joseph Boudreaux, Case No. 2:14-cv-02720, in
the Eastern District of Louisiana.

Trial 2: The Matter of Joseph Orr, Jr., Case No. 2:15-cv-03708, in the
Eastern District of Louisiana.

Trial 4: The Matter of James Henry, individually and as executor for
the Estate of William Henry, Case No. 2:15-cv-00224, in Texas.

Xarelto Lawsuit Status Update: August 4, 2016

On August 4, 2016, the Honorable Eldon Fallon, the Federal Judge
managing most of the Xarelto lawsuits in the United States held a
hearing to discuss trial dates, coordinating the Federal litigation with
the Xarelto litigation in Pennsylvania, and other issues.

Judge Fallon, in essence, ordered that the parties pick specific cases
for trial by August 12, 2016. These cases will be tried in 2017.

Judge Fallon also requested the parties to work with the Xarelto
litigation in Pennsylvania. There are over 800 Xarelto cases in
Pennsylvania and the Honorable Arnold New manages those cases.

Judge New, in Pennsylvania, has directed the parties get 10 cases ready
for trial starting in the Summer of 2017.

In total, Judge Fallon and Judge New manage over 95 percent of the
Xarelto cases in the United States.

At Nastlaw, we litigate cases in front of both Judge Fallon and Judge
New to make sure our clients receive the benefits of the work being done
in both the Xarelto Federal litigation and the Xarelto state litigation.

Nastlaw will continue to update our website about the Xarelto lawsuits
to keep you informed of important developments in the litigation.

Xarelto Lawsuit Status Update: July 2016

The Honorable Eldon Fallon, the Judge who is managing the Xarelto
Federal litigation, has directed the parties to have cases ready for
trial by February 6, 2017. Judge Fallon has set four trials. The first
trial is set to take place in the Eastern district of Louisiana on
February 6, 2017. Judge Fallon has scheduled three other trials to take
place in March, April and May of 2017.

To be able to possess the
instances prepared for trial; Judge Fallon
has ordered the parties to take up to 50 depositions, to become completed by September 23, 2016. These deposition are of
staff of the Defendants who
have been involved the improvement,
advertising and sales of
Xarelto.Additionally, the Defendants have been ordered to produce
approximately 50 million documents also relating to the development,
marketing and sales of Xarelto.

While the Plaintiffs analyze the documents and take the deposition of
Defendants’ witnesses, at the same time, plaintiffs who claim that they
were injured by Xarelto and filed lawsuits, are being deposed by the
Defendants.

By the end of September 2016, approximately 40 cases will be ready to be
tried to a Jury.

Xarelto Lawsuit Status Update: February 2016

The Food and Drug Administration is investigating whether the results of
the pivotal clinical trial used to approve Xarelto, known as the ROCKET
AF trial, are still valid. This clinical trial compared the
effectiveness of Xarelto to Warfarin and showed the two to be roughly
equal in effectiveness. However, the trial results have been called into
question because the device used to measure the amount of Warfarin in
patients’ bodies has been recalled.

In the Xarelto litigation, we are also demanding documents and taking
depositions on this issue. The validity of the ROCKET AF trial is a key
question to whether Xarelto is safe and effective for use in patients
with atrial fibrillation. We will continue to investigate this important
safety issue.

Xarelto Lawsuit Information - Xarelto Lawsuit Claims

Xarelto Lawsuits allege that the manufacturers of Xarelto:

Failed to fully investigate the safety risks of Xarelto

Failed to provide adequate warnings about the true safety risks
associated with the use of Xarelto

Failed to adequately disclose the increased risk of severe bleeding
while taking Xarelto

Failed to adequately disclose that there is no antidote to stop
bleeding from Xarelto

Over promoted the drug to consumers and healthcare professionals,
leading to an explosion in Xarelto sales and putting millions of users
at risk

Question:

What is the Latest Status Update for the Xarelto Litigation Over Bleeds,
Deaths?

Answer:

A growing number of product liability lawsuits continue to be filed in
courts throughout the country on behalf of individuals who allege that
side effects of Xarelto caused severe bleeds and other problems, such as:

Gastrointestinal Bleeding

Brain Bleeding

Hemorrhagic Stroke

Death

The first complaints were filed in early 2014, and by mid-2015 the
number of claims involved in the Xarelto litigation has already reached
2,000. However, our Xarelto injury lawyers believe that several thousand
additional cases are yet to be filed, and the litigation remains
relatively in the early stages.

The lawyers at Saiontz & Kirk, P.A. are continuing to review potential
Xarelto Lawsuit Claims for individuals and family members of Xarelto users who have
been hospitalized or suffered severe injury as a result of bleeding
events that doctors could not stop due to a lack of a Xarelto reversal
agent.

In December 2014, the U.S. Judicial Panel on Multidistrict Litigation
established consolidated proceedings for all Xarelto injury cases,
transferring all complaints filed throughout the federal court system to
U.S. District Judge Eldon Fallon in the Eastern District of Louisiana.

As element in the coordinated
pretrial proceedings, Judge Fallon has indicated that a
tiny group of representative
cases in the
litigation will probably be prepared
for early trial dates to help gauge how juries are
probably to respond to
particular evidence and testimony which is most likely to become
repeated all through numerous other
cases.Throughout most of 2015, it is expected
that the litigation for Xarelto will be focused on the coordination of
discovery from the drug maker, including the review of millions of
internal documents surrounding the research, development and marketing
of the anticoagulant.

The first Xarelto trial dates are not expected to begin until August
2016. While the outcomes will not be binding on other claims, they may
influence eventual negotiations to reach Xarelto settlements.

Allegations Raised in Xarelto Bleeding Litigation

All of the complaints in the Xarelto injury litigation involve similar
allegations that Bayer Healthcare and Johnson & Johnson failed to
adequately warn consumers or the medical community about the risk of
serious and uncontrollable bleeding events associated with the blood
thinner.

Xarelto was released in November 2011, as one of a number of new blood
thinners designed to prevent strokes due to atrial fibrillation. The
drug was launched about a year after its main competitor, Pradaxa.

Drug makers hoped that Xarelto would replace Coumadin (warfarin) as the
go-to drug for atrial fibrillation stroke prevention, and as a
wide-spectrum use blood thinner.

Nevertheless, all blood thinners include the threat of bleeding events. To counteract
that danger, warfarin has an antidote, vitamin K, which
functions as a reversal agent,
enabling physicians to
effortlessly stop and treat warfarin
bleeding events in most instances.

That is not the case with Xarelto. It was released with no reversal
agent and doctors were given no strategy to control Xarelto bleeds. Some
make-shift treatments have been used and developed, but barring a future
Xarelto update, there is no approved Xarelto reversal agent.

Centralized Management of Xarelto Lawsuits

The U.S. JPML decided to establish a federal Xarelto MDL (multidistrict
litigation) in December 2014, which is designed to reduce duplicative
discover, avoid conflicting pretrial rulings and to serve the
convenience of the parties, witnesses and courts.

Similar consolidation occurred in Pradaxa lawsuits, which was the first
member of this new generation of blood thinners to hit the market.
Following several years of litigation, the makers of that anticoagulant
agreed to pay a $680 million settlement to resolve about 4,000 Pradaxa
bleeding claims.

For individuals who suspect they may have a potential claim, it is
important to review your case with a lawyer as soon as possible, as a
Xarelto statute of limitations will limit the amount of time available
in each case to join the litigation.

Thinking About Filing A Xarelto Lawsuit?

If you or a loved one suffered an injury or death because of an adverse
event you believe was caused by Xarelto or Xarelto Lawsuit Claims, then feel free to
contact our compassionate, experienced lawyers today. We will evaluate
your claim and advise you of your legal rights. We are helping families
and individuals all across the United States who believe they have been
wronged by the manufacturers of Xarelto. Call us today. The call is free
and there is no fee for our services until we recover financial
compensation for you.